MIRA INFORM REPORT

 

 

Report Date :

22.02.2013

 

IDENTIFICATION DETAILS

 

Name :

ENALTEC LABS PRIVATE LIMITED

 

 

Registered Office :

1706, 17th Floor, Kesar Solitaire, Plot No.5, Sector – 19, Sanpada, Navi Mumbai 400705, Maharashtra 

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

24.02.2006

 

 

Com. Reg. No.:

11-160020

 

 

Capital Investment / Paid-up Capital :

Rs.14.575 Millions

 

 

CIN No.:

[Company Identification No.]

U73100MH2006PTC160020

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUME06806C

 

 

PAN No.:

[Permanent Account No.]

AABCE5821H

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing and Trading in of Pharmaceuticals Products.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (48)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 900000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Listing :

--

 

 

Banker’s Note :

--

 

 

Comments :

Subject is a subsidiary of ‘Scitech Limited’. It is an established company having satisfactory track record.

 

Trade relations are reported as decent. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

A3+ (Short Term Rating)

Rating Explanation

Having moderate degree of safety regarding timely servicing payment of financial obligation.

Date

December 2012

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office :

1706, 17th Floor, Kesar Solitaire, Plot No.5, Sector – 19, Sanpada, Navi Mumbai 400705, Maharashtra, India

Tel. No.:

91-22-41707000

Fax No.:

91-22-41707070

E-Mail :

info@enalteclabs.co.in

shetty_02@rediffmail.com

sbi.06240@sbi.co.in

anand.shah@enalteclabs.co.in 

Website :

http://www.enalteclabs.co.in

 

 

Factory 1 :

Plot No. N-61, MIDC, Additional Ambernath, District Thane, Mumbai – 421506, Maharashtra, India

 

 

Factory 2 :

Gat No.204, Nashik-Mumbai Highway, Vadicarhe, Taluka Igatpuri, District Nashik – 422403, Maharashtra, India 

 

 

Research and Development Centre :

W – 59 A, Additional Ambernath Industrial Area, Anand Nagar, Ambernath (East), Mumbai – 421501, Maharashtra, India

 

 

DIRECTORS

 

AS ON 29.09.2012

 

Name :

Mr. Anand Prafulchandra Shah

Designation :

Managing Director

Address :

Flat 1204/1205/1206, Bldg 3, Odyssey Kesar, Harmony Plot 11/12, Sector - 6, Kharghar, Mumbai, 410 210, Maharashtra, India

Date of Birth/Age :

09.03.1973

Date of Appointment :

11.11.2008

DIN No.:

00597145

 

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230MH2004PTC146489

PHARMA SERV SOLUTIONS PRIVATE LIMITED

Director

24/05/2004

24/05/2004

03/12/2009

Active

NO

2

U24230MH2005PTC153404

GETZ PHARMA RESEARCH PRIVATE LIMITED

Managing director

01/04/2011

18/05/2005

-

Active

NO

3

U73100MH2006PTC160020

ENALTEC LABS PRIVATE LIMITED

Managing director

11/11/2008

11/05/2007

-

Active

NO

4

U24233MH2007PTC171203

PHARMA SERV VENTURES PRIVATE LIMITED

Director

29/05/2007

29/05/2007

10/05/2010

Active

NO

5

U24232MH2007PTC173479

GETZ PHARMA PRIVATE LIMITED

Director

27/08/2007

27/08/2007

-

Active

NO

 

 

Name :

Mr. Susheel Koul

Designation :

Director

Address :

1601, Bloomingdale, 16th Floor, Hiranandani Estate, GB Road, Thane, 400607, Maharashtra, India

Date of Birth/Age :

01.05.1965

Date of Appointment :

11.11.2008

DIN No.:

00925887

 

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230MH2004PTC146489

PHARMA SERV SOLUTIONS PRIVATE LIMITED

Director

24/05/2004

24/05/2004

03/12/2009

Active

NO

2

U24230MH2005PTC153516

STANTECH PHARMACEUTICALS PRIVATE LIMITED

Director

26/05/2005

26/05/2005

07/11/2009

Active

NO

3

U24233MH2007PTC171203

PHARMA SERV VENTURES PRIVATE LIMITED

Director

07/11/2008

07/11/2008

10/05/2010

Active

NO

4

U73100MH2006PTC160020

ENALTEC LABS PRIVATE LIMITED

Director

11/11/2008

11/11/2008

-

Active

NO

5

U21098MH2012PTC230335

PRINTLINK PLATES PRIVATE LIMITED

Director

27/04/2012

27/04/2012

-

Active

NO

 

 

Name :

Mr. Khalid Mahmood

Designation :

Director

Address :

3013, Sierramills LN, Sacramento, California – 95864, USA

Date of Birth/Age :

07.12.1952

Date of Appointment :

14.11.2008

DIN No.:

02385514

 

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U73100MH2006PTC160020

ENALTEC LABS PRIVATE LIMITED

Director

14/11/2008

14/11/2008

Active

NO

2

U24230MH2005PTC153404

GETZ PHARMA RESEARCH PRIVATE LIMITED

Director

14/11/2008

14/11/2008

Active

NO

3

U24232MH2007PTC173479

GETZ PHARMA PRIVATE LIMITED

Director

30/09/2010

06/10/2009

Active

NO

 

 

Name :

Mr. Prabir Purkayastha

Designation :

Director

Address :

F - 9, Greenwood City, Sector - 46, Gurgaon-122001, Haryana, India

Date of Birth/Age :

01.11.1949

Date of Appointment :

15.03.2010

DIN No.:

01126088

 

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74899DL1990PTC040900

SAGRIK PROCESS ANALYSTS PRIVATE LIMITED

Director

30/03/1992

30/03/1992

-

Active

NO

2

U72200DL1993PTC055269

STARTACUS SOFTWARE PRIVATE LIMITED

Director

17/09/1993

17/09/1993

-

Strike off

NO

3

U93090UR2001GAP026206

ARTISANS TECHNOLOGIES

Director

05/09/2001

05/09/2001

-

Dormant

NO

4

U73100MH2006PTC160020

ENALTEC LABS PRIVATE LIMITED

Director

30/09/2010

15/03/2010

-

Active

NO

5

L74899HR1985PLC034348

KLG SYSTEL LIMITED

Director

24/09/2011

17/01/2011

14/11/2012

Active

NO

 

 

Name :

Mr. Charles Richard Hirschkind

Designation :

Director

Address :

California, California, 94708, United States of America

Date of Birth/Age :

07.10.1957

Date of Appointment :

29.09.2012

DIN No.:

05116062

 

Other Directorship:

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U73100MH2006PTC160020

ENALTEC LABS PRIVATE LIMITED

Director

29/09/2012

09/11/2011

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 29.09.2012

 

Names of Equity Shareholders

No. of Shares

Scitech Limited

873112

Anand Prafulchandra Shah

149676

Susheel Koul

149676

Siva Kumar

74836

TOTAL

1247300

 

 

Names of Preference Shareholders

No. of Shares

Medtech Limited

210245

TOTAL

210245

 

AS ON 29.09.2012

 

Equity Shares Break Up

Percentage of Holding

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

70.00

Directors or relatives of Directors

30.00

TOTAL

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Trading in of Pharmaceuticals Products.

 

 

Products :

Product Description

Item Code No.:

Moxifloxacin

GydrocGloride

MonoGydrate Ep

2934 9900

Montelukast Sodium

2993 4990

Rosuvastain Calcium

2942 0090

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         State Bank of Mauritius Limited, 101, Raheja Centre, Free Journal Road, Nariman Point, Mumbai-400021, Maharashtra, India

·         Central Bank of India, 1st Floor, Bajaj Bhavan, Nariman Point, Mumbai-400021, Maharashtra, India

 

 

Facilities :

Secured Loan

 

Rs. In Millions

31.03.2012

Rs. In Millions

31.03.2011

Long Term Borrowings

 

 

From Banks

(Secured by first and exclusive charge on (i) movable fixed assets of the Company and (ii) immovable fixed assets of the company located at Plot No. N-61, Addl. MIDC Ambernath, Thane, Maharashtra)

31.800

47.700

(The term loans are guaranteed by (i) Mr. Anand Shah (ii) Mr. Susheel Koul (iii) Dr. B V Sivakumar)

Terms of repayment: 51 equal monthly installment, commencing from January 2011. Last installment due on March, 2013.

 

 

Vehicle Loan from bank

(Secured by hypothecation of vehicles financed by respective lenders.)

0.697

1.559

Terms of Repayment : Repayable as per respective EMI schedules

 

 

Vehicle Loan from Others

(Secured by hypothecation of vehicles financed by respective lenders)

0.334

0.000

Terms of Repayment : Repayable as per respective EMI schedules

 

 

Short Term Borrowings

 

 

Loans repayable on demand

 

 

From Banks

(Secured by way of (i) hypothecation of current assets of the company (ii) hypothecation of movable fixed assets of the company (iii) mortgage on immovable fixed asset of the Company located at Plot No. N-61, Addli. MIDC, Ambernath, Thane, Maharashtra)

118.806

117.915

(The borrowings are guaranteed by (i) Mr. Anand Shah (ii) Mr. Susheel Koul (iii) Dr. B V Sivakumar) )

 

 

 

 

 

TOTAL

151.637

167.174

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Shankarial Jain and Associates

Chartered Accountant

Address :

12, Enginner Building, 265, Princess Street, Mumbai-400002, Maharashtra, India

Tel. No.:

91-22-22036623 / 22065739

Fax No.:

91-22-22086269

E-Mail :

info@sljainindia.com

PAN No.:

AACFS6967Q

 

 

Holding Company :

Scitech Limited

 

 

Related Parties :

·         Getz Pharma Research Private Limited

·         Getz Pharma Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

1300000

Equity Shares

Rs.10/- each

Rs. 13.000 Millions

210500

Preference Shares

Rs.10/- each

Rs. 2.105 Millions

 

TOTAL

 

Rs. 15.105 Millions

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

1247300

Equity Shares

Rs.10/- each

Rs. 12.473 Millions

210245

Preference Shares

Rs.10/- each

Rs. 2.102 Millions

 

TOTAL

 

Rs. 14.575 Millions

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

14.575

13.059

7.237

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

210.899

152.900

69.617

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

225.474

165.959

76.854

LOAN FUNDS

 

 

 

1] Secured Loans

151.637

167.174

146.023

2] Unsecured Loans

27.004

2.380

50.417

TOTAL BORROWING

178.641

169.554

196.440

DEFERRED TAX LIABILITIES

6.186

11.395

5.184

 

 

 

 

TOTAL

410.301

346.908

278.478

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

288.044

277.573

231.691

Capital work-in-progress

0.000

0.000

0.820

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

133.727
128.873
47.896

 

Sundry Debtors

191.444
159.849
118.014

 

Cash & Bank Balances

14.951
9.720
24.217

 

Other Current Assets

1.456
1.755
0.000

 

Loans & Advances

49.082
53.640
69.475

Total Current Assets

390.660

353.837

259.602

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

168.578
196.706
186.627

 

Other Current Liabilities

88.599
81.937
25.203

 

Provisions

11.226
5.859
1.813

Total Current Liabilities

268.403

284.502

213.643

Net Current Assets

122.257
69.335
45.959

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.008

 

 

 

 

TOTAL

410.301

346.908

278.478

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

676.067

615.944

392.987

 

 

Other Income

3.936

5.730

 

 

 

TOTAL                                     (A)

680.003

621.674

392.987

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

259.583

327.122

388.769

 

 

Purchases of Stock In Trade

118.226

96.922

 

 

 

Employee benefits expenses

45.585

41.367

 

 

 

Other expenses

163.553

128.279

 

 

 

Changes in inventories of finished goods work in progress and stock in trade

0.051

(35.961)

 

 

 

TOTAL                                     (B)

586.998

557.729

388.769

 

 

 

 

 

Less

PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

93.005

63.945

[Including

Financial

 

 

 

 

Expenses

Less

FINANCIAL EXPENSES                         (D)

32.436

32.449

And

 

 

 

 

Depreciation ]

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

60.569

31.496

 

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

20.217

14.449

 

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX (E-F)                 (G)

40.352

17.047

4.218

 

 

 

 

 

Less

TAX                                                                  (H)

3.587

9.937

0.805

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX (G-H)                  (I)

36.765

7.110

3.413

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

536.998

411.997

334.458

 

TOTAL EARNINGS

536.998

411.997

334.458

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

117.608

136.434

68.547

 

TOTAL IMPORTS

117.608

136.434

68.547

 

 

 

 

 

 

Earnings Per Share (Rs.)

29.46

6.95

5.22

 

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

5.41

1.14

0.87

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

5.97

2.77

NA

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

5.95

2.70

0.86

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.18

0.10

0.05

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.79

1.02

2.56

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.46

1.24

1.22

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

UNSECURED LOAN

 

Rs. In Millions

31.03.2012

Rs. In Millions

31.03.2011

Long Term Borrowings

 

 

Term Loans

 

 

From Banks

Terms of Repayment:36 Equal Monthly installment commencing from December 2010 and ending in December 2013

0.398

0.920

Other loans and advances

25.524

0.000

Short Term Borrowings

 

 

Loans repayable on demand

 

 

Terms of repayment: 12 equal monthly installment, commencing from September 2011. Last installment due on August, 2012

1.082

1.460

 

 

 

TOTAL

27.004

2.380

 

NOTES

 

Long Term Borrowings

 

PARTICULARS

NON CURRENT PORTION

CURRENT MATURITIES

TOTAL

Term Loan

31.800

15.900

47.700

Vehicle Loan

1.031

0.958

1.989

Others

25.922

0.523

26.445

 

58.753

17.381

76.134

 

NOTE

 

The registered office address of the company has been shifted from “1704-1706, 17th Floor, Kesar Solitaire, Plot No. 5, Sector-19, Sanpada Navi Mumbai – 400705, Maharashtra, India” to present address w. e. f. 01.02.2011.

 

 

FORM 8

 

Corporate identity number of the company

U73100MH2006PTC160020

Name of the company

ENALTEC LABS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

1706, 17th Floor, Kesar Solitaire, Plot No. 5, Sector-19, Sanpada Navi Mumbai – 400705, Maharashtra, India

E-mail id : anand.shah@enalteclabs.co.in

This form is for

Creation of charge

Type of charge

·         Movable property (not being pledge)

Particular of charge holder

State Bank of Mauritius Limited, 101, Raheja Centre, Free Journal Road, Nariman Point, Mumbai-400021, Maharashtra, India

Nature of instrument creating charge

Deed of Hypothecation

Date of instrument Creating the charge

21.12.2012

Amount secured by the charge

Rs. 12.500 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of interest

SBM Base Rate + 3.50% p.a. presently 14.50% p.a. SBM base rate is 11.0 % p.a.

 

Terms of repayment

Capital : in 10 quarterly installments of INR 1.25 million starting from 31 December, 2012

Interest : to be serviced monthly

 

Margin

As per agreement

 

Extent and operation of the charge

First charge on the movable machinery and equipment, both present and future, of the Company, financed out of the Term Loan from the Bank.

Short particulars of the property charged (Including location of the property)

First charge on the movable machinery and equipment, both present and future, of the Company, financed out of the Term Loan from the Bank.

 

FIXED ASSETS

 

·         Land

·         Factory Building

·         Leasehold Improvements 

·         Office Premises  

·         Plant and Machinery

·         Furniture and Fixtures

·         Vehicles

·         Patents

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 54.48

UK Pound

1

Rs. 82.71

Euro

1

Rs. 72.23

 

 

INFORMATION DETAILS

 

Report Prepared by :

DPT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

48

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.